Current Report Filing (8-k)
July 18 2017 - 8:41AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF EARLIEST EVENT REPORTED – July 12, 2017
GILLA INC.
(Exact
Name of Registrant as Specified in its Charter)
NEVADA
|
|
000-28107
|
|
88-0335710
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation)
|
|
File
Number)
|
|
Identification
Number)
|
475 Fentress Blvd., Unit L, Daytona Beach, Florida
32114
(Address of principal executive offices)
(416) 843-2881
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities
Act
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act
|
Indicate
by check
mark whether the registrant
is an
emerging growth company as defined in in Rule 405 of
the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of
this chapter).
Emerging
growth company
☐
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
☐
Item 8.01
Other Events.
On July
12, 2017, Gilla Inc. (“Gilla” or the
“Company”) issued a press release announcing that the
Company’s subsidiary, Gilla Enterprises Inc., has entered
into a non-binding letter of intent (the “LOI”) with a
Canadian Licensed Producer (the “LP”) under the
Access to Cannabis for Medical
Purposes Regulations
(Canada) (“ACMPR”). Under
the terms of the LOI, the Company’s subsidiary and the LP
would enter into a definitive agreement to provide both
private-label and branded cannabis vapor solutions for the LP to
produce and distribute in Canada through the LP’s authorized
distribution channels.
A copy
of such press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
|
Press
Release dated July 12, 2017 from Gilla Inc.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
GILLA
INC.
|
|
|
|
|
|
Dated: July 17,
2017
|
By:
|
/s/
Graham
Simmonds
|
|
|
|
Name:
Graham
Simmonds
|
|
|
|
Title:
Chief
Executive Officer
|
|